Advances in the use of topical imiquimod to treat dermatologic disorders
Francesco Lacarrubba, Maria Rita Nasca, Giuseppe MicaliDermatology Clinic, University of Catania, ItalyAbstract: Imiquimod (IQ) is an immune-response modifying agent, first approved by FDA for the topical treatment of external genital and perianal warts in 1997. It induces, through stimulation of To...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/fd26d7300cda4cdfbe3f91c66ae89725 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|